Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
|ClinicalTrials.gov Identifier: NCT00943527|
Recruitment Status : Completed
First Posted : July 22, 2009
Last Update Posted : January 25, 2012
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||110 participants|
|Official Title:||Molecular Breast Imaging: Effect of Menstrual Cycle, Hormone Therapy, and Tamoxifen on Tc-99m Sestamibi Uptake in the Breast.|
|Study Start Date :||January 2008|
|Primary Completion Date :||December 2010|
|Study Completion Date :||January 2012|
Premenopausal Women who are not taking hormones or birth control. Ages 35-45 who have had a negative mammograph performed at the Mayo Clinic in Rochester within the last year.
Women Initiating Hormone Therapy and have had a negative mammogram preformed at the Mayo Clinic Rochester within the last year.
Women Initiating Tamoxifen who have had a negative mammogram preformed at the Mayo Clinic Rochester.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00943527
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|